Nouvelles

Cette section contient des nouvelles liées au pharmaceutique industrie.

Éditeurs de pharmaceutique les nouvelles relatives peuvent inscription à libre sur notre site Web et ajoutez le leur pharmaceutique nouvelles à ce site Web.

Pharmaceutical News

Orexigen Partners With Takeda To Commercialize Obesity Drug Contrave (Naltrexone SR/Bupr ...
Thu, 02 September 2010
Contrave (naltrexone SR/bupropion SR), an investigational drug aimed at combination therapy to address both biological and behavioral drivers of obesity, will be developed and commercialized by Orexigen Therapeutics, Inc. and Takeda Pharmaceutical Company Limited in the USA, Canada and Mexico. The two drug firms have just si ...
Therapeutic Workshops To Highlight Opportunities In Biotech At 9th Annual BIO Investor Forum
Thu, 02 September 2010
BIO today announced the preliminary set of speakers who will be featured on the Therapeutic Workshops during the 9th Annual BIO Investor Forum - a national meeting focused on investment trends and opportunities in the life-sciences with a focus on public and venture-stage growth companies...
Roche Provides Update On FDA Application For T-DM1
Thu, 02 September 2010
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the U.S. Food and Drug Administration (FDA) issued a Refuse to File letter for accelerated approval for the company's trastuzumab-DM1 (T-DM1) Biologics License Application (BLA). As planned Roche will continue with its ongoing Phase III EMILIA registration study...
Novartis Drug Tasigna Approved In Switzerland After Fast-track Review For Treatment Of P ...
Thu, 02 September 2010
The Swiss health authority Swissmedic has granted approval for Tasigna (nilotinib) 300 mg twice daily for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph CML) in chronic phase...
BRINAVESS? (vernakalant) For Infusion Approved In The European Union For Rapid Conversio ...
Thu, 02 September 2010
Merck (known as MSD outside the United States and Canada) (NYSE:MRK) and Cardiome Pharma Corp...
Eisai Announces The Start Of The First Clinical Study Of Ban2401, A Novel Monoclonal Ant ...
Thu, 02 September 2010
Eisai Co., Ltd. (Headquarters: Tokyo, Japan, President & CEO: Haruo Naito, Eisai) announced today the start of the first patient enrolled clinical study with BAN2401, a novel monoclonal antibody that is being developed as a potential next-generation therapeutic treatment for Alzheimer's disease...
Actavis Receives FDA Approval Of Atomoxetine HCl Capsules
Thu, 02 September 2010
Actavis has received approval from the U.S. Food & Drug Administration to market Atomoxetine HCl capsules for the treatment of attention deficit/hyperactivity disorder (ADHD). Actavis intends to market Atomoxetine HCl in 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg and 100 mg strengths...
Microplasmin Meets Primary Endpoint In Second Phase III Trial In VMA, Confirms Positive ...
Thu, 02 September 2010
ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer announces that its second Phase III trial evaluating microplasmin for the non-surgical treatment of vitreomacular adhesion (VMA) has met its pri ...
ReVision's Fenretinide (RT-101) Reduced Incidence Of Choroidal Neovascularization By Mor ...
Thu, 02 September 2010
ReVision Therapeutics Inc. announced that data from a Phase 2b trial show that fenretinide (RT-101) reduced the incidence of choroidal neovascularization (CNV, wet age related macular degeneration) by about 50 percent in patients with geographic atrophy (GA), the most advanced form of dry age related macular degeneration (AM ...
Proprietary Zinc/Phytase Formulation Improved Botulinum Toxin A Results
Thu, 02 September 2010
A recent study conducted by oculoplastic surgeon Charles Soparkar, M.D., Ph.D. (The Methodist Hospital, Houston, TX) utilizing a patent-pending formulation of zinc and phytase (trademarked as ZYTAZE?), demonstrated that increasing zinc levels by oral administration for 4 days prior to a planned injection of botulinum toxin i ...

Annonces

Laboratory Supplies 1.com

Medical Products 1.com

Medicines 1.com

Pet Products 1.com

Veterinary Products 1.com

Plus de sites Web de 1.com.

- Au sujet de nous
- Au sujet de Pharmaceuticals 1.com
- Envoyez-nous
- Limites d'utilisation
- Using Pharmaceuticals 1.com
- Enregistrez (libre)
- Adhésions
- Comment pour acheter/vente
- FAQ/aide

Pharmaceutical News - Pharmaceuticals 1.com

Membres dedans

Algérie
Angola
Bénin
Burundi
Cameroun
Ivoire de Cote
Djibouti
Ethiopie
Gambie
Ghana
Kenya
Lesotho
Libéria
Libye
Malawi
Mali
Mauritanie
Les Îles Maurice
Maroc
Mozambique
Namibie
Niger
Nigéria
Sénégal
Sierra Leone
Somalie
Afrique du sud
Soudan
Tanzanie
Togo
Tunisie
Ouganda
Zaïre
Zambie
Zimbabwe
Afghanistan
Bangladesh
Bermudes
Brunei Darussalam
Cambodge
Chine
Hong Kong
Inde
Indonésie
Japon
Kazakhstan
Kyrgyzstan
Malaisie
Mongolie
Myanmar
Népal
Pakistan
Nouvelle-Guinée Papua
Philippines
Singapour
Corée, République de
Sri Lanka
Taïwan
Tajikistan
Thaïlande
Vietnam
Albanie
Arménie
Autriche
Azerbaïdjan
Belarus
Belgique
Bulgarie
Croatie
Chypre
République Tchèque
Danemark
Estonie
Finlande
France
Géorgie
Allemagne
Grèce
Hongrie
Islande
Irlande
Italie
Lettonie
Lithuanie
Luxembourg
Macédoine
Malte
Moldau, République de
Pays Bas (Hollande)
Norvège
Pologne
Portugal
Serbie
Roumanie
Fédération Russe
Slovaquie
Slovénie
Espagne
Suède
Suisse
Turquie
Ukraine
Royaume-Uni
Uzbekistan
État De Ville De Vatican
Yougoslavie
Bahrain
Egypte
Iran
Irak
Israel
Jordanie
Kowéit
Liban
Oman
Qatar
Arabie Saoudite
Souaziland
Syrie
Emirats Arabes Unis
Yémen
Antigua et Barbuda
Aruba
Bahamas
Barbades
Belize
Canada
Costa Rica
Cuba
République Dominicaine
Salvador
Guatemala
Haïti
Honduras
Jamaïque
Mexique
Pays Bas Antilles
Nicaragua
Panama
Porto Rico
Trinité-et-Tabago
Etats-Unis
Australie
Fiji
Nouvelle Zélande
Mariannes du Nord
Saint Vincent et les Grenadines
Îles Périphériques Mineures Des Etats-Unis
Argentine
Bolivie
Brèsil
Chili
colombie
Equateur
Guyane
Paraguay
Pérou
Surinam
Uruguay
Venezuela
Gabon
Bosnie et Herzégovine
Saint-Marin
Samoa américaines
Congo
Guinée équatoriale
Île De Bouvet
Grenada
Antarctique